Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New study aims to Fine-Tune cochlear implant settings for sharper hearing

NCT ID NCT07476079

Knowledge-focused Sponsor: Luzerner Kantonsspital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study will test two methods for programming electric acoustic stimulation (EAS) in cochlear implant users who still have some natural hearing. One method uses electrical measurements from the inner ear, while the other uses standard hearing tests. The goal is to see which approach leads to better speech understanding in noisy environments. Twelve adults aged 18-85 who are candidates for a MED-EL cochlear implant will participate.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Electric acoustic stimulation (EAS) fitting methods
What this could lead to
If successful, this study could point toward a more effective way to program cochlear implants for people with residual hearing, potentially improving speech understanding in noise.
What could go wrong
This is a very small early-stage study with only 12 participants, so results may not apply to everyone. The fitting methods are being compared, not tested for safety or long-term benefit.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 12 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

May 2026

An estimate. Start dates often move.

Expected to finish

Nov 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 85 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Patients aged between 18-85 years. 2. Cochlear Implant (CI) candidates with measurable post-operative low-frequency residual hearing (125Hz \<65dB, 250Hz \<65dB, 500Hz \<65dB). 3. Only patients with MED-EL EAS. 4. Written informed consent must be obtained prior to study start. Exclusion Criteria: 1. Patients with cognitive impairments who, as a result, lack the capacity to make decisions. 2. Uncooperative patients regarding pure tone audiometry thresholds measurements. 3. Morbus Menière or intracochlear/ vestibular schwannoma

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Fitting methods by eas patients are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

hearing loss disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Fitting methods by eas patients

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  2. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

More trials for these conditions

Other studies related to the condition(s) this trial covers.